151 related articles for article (PubMed ID: 7658750)
1. Phospholipid antitumor agents.
Houlihan WJ; Lohmeyer M; Workman P; Cheon SH
Med Res Rev; 1995 May; 15(3):157-223. PubMed ID: 7658750
[No Abstract] [Full Text] [Related]
2. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.
Gajate C; Mollinedo F
Curr Drug Metab; 2002 Oct; 3(5):491-525. PubMed ID: 12369895
[TBL] [Abstract][Full Text] [Related]
3. 1-O-octadecyl-2-O-methylglycero-3-phosphocholine (Edelfosine) and cancer cell invasion: a short review.
Van Slambrouck S; Steelant WF
Anticancer Agents Med Chem; 2014 May; 14(4):539-44. PubMed ID: 24628232
[TBL] [Abstract][Full Text] [Related]
4. Ether lipids in the therapy of cancer.
Andreesen R
Prog Biochem Pharmacol; 1988; 22():118-31. PubMed ID: 3043427
[No Abstract] [Full Text] [Related]
5. Membrane-interactive lipids as experimental anticancer drugs.
Berdel WE
Br J Cancer; 1991 Aug; 64(2):208-11. PubMed ID: 1892746
[No Abstract] [Full Text] [Related]
6. Edelfosine in membrane environment - the Langmuir monolayer studies.
Dynarowicz-Latka P; Hac-Wydro K
Anticancer Agents Med Chem; 2014 May; 14(4):499-508. PubMed ID: 24628234
[TBL] [Abstract][Full Text] [Related]
7. [Alkylglycerolipids--modulators of tumor cells death].
Romanova SG; Romanov VG; Serebrennikova GA; Shtil' AA
Biomed Khim; 2010; 56(4):457-70. PubMed ID: 21032896
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of the spin-labeled derivative of an ether-linked phospholipid possessing high antineoplastic activity.
Joseph J; Shih CC; Lai CS
Chem Phys Lipids; 1991; 58(1-2):19-26. PubMed ID: 1657423
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of the R- and S-enantiomers of RS-2-[[hydroxy[[2-[ (octadecyloxy)methyl]tetrahydrofuran-2-yl]methoxy]-phosphinyl]oxy]-N, N,N,-trimethylethylaminium hydroxide inner salt.
Houlihan WJ; Prasad K; Underwood R; Repic O; Munder PG
J Med Chem; 1996 Jan; 39(2):605-8. PubMed ID: 8558533
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
Leder GH; Fiebig HH; Wallbrecher E; Winterhalter BR; Löhr GW
Lipids; 1987 Nov; 22(11):958-61. PubMed ID: 3444393
[TBL] [Abstract][Full Text] [Related]
11. NMR spectral analysis of cytotoxic ether lipids.
Dick D; Pluskey S; Sukumaran DK; Lawrence DS
J Lipid Res; 1992 Apr; 33(4):605-9. PubMed ID: 1527483
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of cell signaling pathways by antitumor ether lipids.
Arthur G; Bittman R
Biochim Biophys Acta; 1998 Feb; 1390(1):85-102. PubMed ID: 9487143
[No Abstract] [Full Text] [Related]
14. Antitumor ether lipids: endocytosis as a determinant of cellular sensitivity.
Workman P
Cancer Cells; 1991 Aug; 3(8):315-7. PubMed ID: 1657088
[No Abstract] [Full Text] [Related]
15. Antitumor activity of a piperidine phospholipid.
Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
[TBL] [Abstract][Full Text] [Related]
16. Ether lipids and analogues.
Fleer EA
J Cancer Res Clin Oncol; 1988; 114(6):655-6. PubMed ID: 3204115
[No Abstract] [Full Text] [Related]
17. Edelfosine: An Antitumor Drug Prototype.
Teixeira SF; Rodrigues CP; Costa CJS; Pettinati TN; de Azevedo RA; Mambelli LI; Jorge SD; Ramos RN; Ferro ES; Barbuto JAM; Ferreira AK
Anticancer Agents Med Chem; 2018; 18(6):865-874. PubMed ID: 29308743
[TBL] [Abstract][Full Text] [Related]
18. Glycosylated antitumor ether lipids: activity and mechanism of action.
Arthur G; Bittman R
Anticancer Agents Med Chem; 2014 May; 14(4):592-606. PubMed ID: 24628233
[TBL] [Abstract][Full Text] [Related]
19. [Purging of leukemic cells using alkyllysophospholipid].
Okamoto S; Shoji M
Rinsho Ketsueki; 1992 Jul; 33(7):908-12. PubMed ID: 1507412
[No Abstract] [Full Text] [Related]
20. Advances in either phospholipids treatment of cancer.
Principe P; Braquet P
Crit Rev Oncol Hematol; 1995 Mar; 18(3):155-78. PubMed ID: 7695830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
